4/A//SEC Filing
Loew Caroline 4/A
Accession 0000950170-24-043842
CIK 0001971543other
Filed
Apr 10, 8:00 PM ET
Accepted
Apr 11, 9:10 PM ET
Size
6.2 KB
Accession
0000950170-24-043842
Insider Transaction Report
Form 4/AAmended
Loew Caroline
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-12-14+379,690→ 379,690 totalExercise: $5.48Exp: 2033-07-02→ Ordinary Shares (379,690 underlying)
Footnotes (3)
- [F1]This amendment to Form 4 is being filed solely to correct the exercise price of the granted option, which was previously reported as being $3.61 due to a scrivener's error.
- [F2]Represents an option award originally granted by Alkermes plc ("Alkermes") that was converted into an option award of Mural Oncology plc (the "Issuer") in connection with the spin-off of the Issuer from Alkermes.
- [F3]This option was granted on December 14, 2023. The option is scheduled to vest with respect to 25% of the underlying ordinary shares on each of the first four anniversaries of July 5, 2023, subject to the reporting person's continued service with the Issuer.
Documents
Issuer
Mural Oncology plc
CIK 0001971543
Entity typeother
Related Parties
1- filerCIK 0001989488
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 10, 8:00 PM ET
- Accepted
- Apr 11, 9:10 PM ET
- Size
- 6.2 KB